Dr Sayan Sinha Roy, assistant professor in the department of hematology, said hematopoietic stem cell transplantation (HSCT), commonly known as a bone marrow transplant, is “currently the only established treatment capable of stopping the progression of X-ALD,” provided it is performed before permanent neurological damage occurs.